HQH News Alert Tekla Healthcare Investors (HQH) 31.44 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tekla Healthcare Investors (HQH) 31.44 $HQH

H&Q Healthcare Investors Shares Up 16.2% Since SmarTrend's Buy Recommendation (HQH)
Comtex SmarTrend(R) - Fri Dec 19, 9:18AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 2 months, H&Q Healthcare Investors has returned 16.18% as of today's recent price of $33.57.
HQH: 31.44 (+0.74)

H&Q Healthcare Investors Has Returned 15.3% Since SmarTrend Recommendation (HQH)
Comtex SmarTrend(R) - Wed Dec 10, 10:01AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 2 months, H&Q Healthcare Investors has returned 15.35% as of today's recent price of $33.33.
HQH: 31.44 (+0.74)

CardioKinetix Completes $50 Million Financing and Signs Agreement With Edwards Lifesciences, Including Exclusive Option to Purchase
Business Wire - Mon Dec 08, 9:00AM CST
CardioKinetix, Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has completed a $50 million financing led by Edwards Lifesciences Corporation, with participation from existing investors U.S. Venture Partners, Tekla Healthcare Investors (NYSE:HQH), Tekla Life Sciences Investors (NYSE:HQL), SV Life Sciences, Panorama Capital, New Leaf Venture Partners, and Lexington Private Equity.
HQL: 24.59 (+0.49), EW: 130.75 (+1.17), HQH: 31.44 (+0.74)

Uptrend Call Working As H&Q Healthcare Investors Stock Rises 15.7% (HQH)
Comtex SmarTrend(R) - Wed Dec 03, 9:58AM CST
SmarTrend identified an Uptrend for H&Q Healthcare Investors (NYSE:HQH) on October 21st, 2014 at $28.90. In approximately 1 month, H&Q Healthcare Investors has returned 15.66% as of today's recent price of $33.42.
HQH: 31.44 (+0.74)

Update: Double-Digit Distribution Portfolio
Left Banker - at Seeking Alpha - Tue Dec 02, 2:42AM CST

PDI: 30.38 (-1.64), NFJ: 16.84 (-0.43), PCI: 20.57 (-0.39), IGA: 12.29 (+0.08), DVHL: 23.82 (-0.17), SDRL: 11.90 (+0.04), MORL: 21.08 (-0.33), GGN: 6.65 (+0.03), BQR: 7.57 (+0.01), EOS: 14.02 (+0.03), JRI: 19.06 (+0.08), BIT: 17.28 (+0.24), BOE: 13.49 (+0.03), EDI: 15.42 (+0.06), ETV: 15.18 (+0.10), FFC: 20.75 (unch), OXLC: 14.52 (-0.14), EDF: 15.76 (+0.21), HQH: 31.44 (+0.74), STK: 19.00 (-0.21), TYG: 43.73 (unch)

Tekla Healthcare Opportunities Fund Pays Distribution
Business Wire - Fri Nov 28, 8:37AM CST
On November 28, 2014, Tekla Healthcare Opportunities Fund paid a monthly stock distribution of $0.1125 per share. It is currently estimated that this distribution is derived from short-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $74,341,984, of which $60,210,049 represents net unrealized appreciation of portfolio securities.
HQL: 24.59 (+0.49), THQ: 19.75 (+0.07), HQH: 31.44 (+0.74)

Tekla Healthcare Opportunities Introduces Fact Card
Business Wire - Tue Nov 18, 10:44AM CST
Tekla Healthcare Opportunities Fund (NYSE: THQ) is pleased to introduce its first fact card. The fact card, which summarizes Fund information which may include quarterly data regarding the Fund including performance, portfolio holdings and sector information, will be available at www.teklacap.com or by request from the Fund's marketing and support services agent, Destra Capital Investments at (877)855-3434. The Fund intends to publish and distribute fact cards with quarterly data within approximately 15 days after each quarter's end. Please visit the Fund's website or call Destra Capital Investments to obtain the Fund's fact cards as published.
HQL: 24.59 (+0.49), THQ: 19.75 (+0.07), HQH: 31.44 (+0.74)

Tekla Healthcare Investors Declares Stock Distribution
Business Wire - Fri Nov 14, 9:37AM CST
On November 14, 2014, Tekla Healthcare Investors (formerly H&Q Healthcare Investors) declared a stock distribution of $0.59 per share. The record date for the stock distribution is November 26, 2014 and the payable date is December 31, 2014. The Fund will trade ex-distribution on November 24, 2014.
HQH: 31.44 (+0.74)

Equity CEFs: Funds To Buy And Sell Heading Into 2015
Douglas Albo - at Seeking Alpha - Mon Oct 27, 4:56PM CDT

ETG: 16.54 (-0.03), KYE: 28.10 (+0.05), AWP: 6.59 (-0.05), HQL: 24.59 (+0.49), SCD: 16.82 (-0.01), CEM: 26.87 (+0.34), ETO: 26.12 (+0.05), PGP: 19.88 (+0.24), SPY: 207.77 (+0.02), EVT: 20.94 (+0.09), RFI: 13.16 (+0.04), GRX: 10.58 (+0.10), NTG: 27.34 (+0.19), UTF: 22.89 (+0.15), HQH: 31.44 (+0.74), RQI: 12.06 (+0.01)

H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Name Changes
Business Wire - Wed Oct 15, 12:00PM CDT
We are pleased to announce that H&Q Healthcare Investors (NYSE: HQH) and H&Q Life Sciences Investors (NYSE: HQL) have changed their names to Tekla Healthcare Investors and Tekla Life Sciences Investors, respectively. The Funds will continue to trade on the NYSE under their current tickers, HQH and HQL. The Funds name changes are designed to reflect continuity amongst the three Funds managed by Tekla Capital Management LLC.
HQL: 24.59 (+0.49), THQ: 19.75 (+0.07), HQH: 31.44 (+0.74)

H&Q Healthcare Investors Pays Stock Distribution
Business Wire - Wed Oct 01, 10:08AM CDT
On September 30, 2014, H&Q Healthcare Investors paid a quarterly stock distribution of $0.56 per share. It is currently estimated that $0.46 of this distribution is derived from long-term capital gains and $0.10 from short-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on the sale of securities is $489,660,986, of which $398,062,384 represents net unrealized appreciation of portfolio securities.
HQH: 31.44 (+0.74)

Tekla Healthcare Opportunities Fund (THQ) Announces Initial Monthly Cash Distribution
Business Wire - Wed Aug 27, 7:59AM CDT
On August 27, 2014, Tekla Healthcare Opportunities declared its initial monthly cash distribution of $0.1125 per share. This represents an annualized distribution rate of 6.75% based upon the Fund's IPO market price of $20.00. The record date for the monthly cash distribution is September 19, 2014 and the payable date is September 30, 2014. The Fund will trade ex-distribution on September 17, 2014.
HQL: 24.59 (+0.49), THQ: 19.75 (+0.07), HQH: 31.44 (+0.74)

H&Q Healthcare Investors Declares Stock Distribution
Business Wire - Mon Aug 18, 8:41AM CDT
On August 18, 2014, H&Q Healthcare Investors declared a stock distribution of $0.56 per share. The record date for the stock distribution is August 29, 2014 and the payable date is September 30, 2014. The Fund will trade ex-distribution on August 27, 2014.
HQH: 31.44 (+0.74)

Tekla Capital Management LLC Successfully Launches Tekla Healthcare Opportunities Fund (THQ)
Business Wire - Thu Jul 31, 4:45PM CDT
Tekla Capital Management LLC is pleased to announce the successful initial public offering of Tekla Healthcare Opportunities Fund (NYSE: THQ or the "Trust" , a closed-end management investment company managed by Tekla Capital Management LLC ("Tekla" .
HQL: 24.59 (+0.49), THQ: 19.75 (+0.07), HQH: 31.44 (+0.74)

H&Q Healthcare Investors Announces Completion of its Rights Offering
Business Wire - Wed Jun 25, 11:14AM CDT
H&Q Healthcare Investors (the "Fund" (NYSE: HQH) is pleased to announce the completion of its one for three non-transferable rights offering which expired Monday, June 23, 2014 (the "Offering" . Pursuant to the Offering, record date shareholders were entitled to purchase one newly issued share of the Fund for every three non-transferrable right held. The subscription price for each newly issued share was determined to be $25.037 which, under the terms of the prospectus, was equal to 95% of the volume weighted average price of a share on the NYSE on June 24, 2014 and the three preceding business days.
HQH: 31.44 (+0.74)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Epiroc Takes Live Remote Drilling to CES 2027 Stage

Updated Category News Views 48

A drill rig chewing through Virginia rock from a Las Vegas convention booth is either a serious industrial-tech moment or an expensive magic trick. At CES 2027, Epiroc intends to make the distinction painfully clear. From January 6 through 9, the Stockholm-based mining-equipment company and Luck Stone will connect Booth 7031 in the LVCC West Hall to a working quarry in...

Continue Reading
Fire-Resistant Lubricants Offer a Quiet Value Shift

Updated Category News Views 67

Hydraulic fluid is not the sort of product that gets anyone pounding the table, and that is precisely why this little industrial pocket deserves a hard look. The fire-resistant lubricants market is estimated at $2.35 billion in 2026 and projected to reach $2.83 billion by 2031, implying a 3.74% compound annual growth rate. That is not a rocket ship. It is a slow-moving,...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 53

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Foresight Solar Insurance Trial Beats Fixed PPA Route

Updated Category News Views 107

Six solar sites and one settled insurance contract have produced a result worth studying, not celebrating with confetti. Foresight and Paratus say their completed renewable-price insurance policy generated a £14.49/MWh net uplift, after premium, against the revenue those assets would have earned under a fixed-price power purchase agreement. In a UK renewables market...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Automus and Google Cloud Put Agents to Work on Oracle

Updated Category News Views 96

Oracle back offices are where shiny AI promises go to earn their keep, or get buried under a mountain of integrations. Automus Consulting’s newly announced collaboration with Google Cloud, unveiled November 20 at Oracle AI World, is aimed squarely at that messy middle. The firm wants to combine its Oracle implementation experience with Google Cloud infrastructure and...

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 76

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 35

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading

Top 5 Most Recently Viewed Articles

Synetos Aerospace Partners with AFWERX for AI Flight System

Updated Category News Views 202

Synetos Aerospace made waves back when it teamed up with AFWERX to develop an AI-enabled flight augmentation system aimed at improving the safety and efficiency of uncrewed aircraft. This partnership was not just about spiffing up tech; it showcased a commitment to enhancing operational productivity while lightening the load for operators in the increasingly fast-paced...

Continue Reading
Haruhiko Kuroda Takes on New Role at Economic Research Center

Updated Category News Views 256

Haruhiko Kuroda's New Chapter in Economic Research Former Bank of Japan Governor Haruhiko Kuroda is set to begin an exciting new role as an adviser at the Japan Center for Economic Research starting in January. This significant change comes on the heels of his long and impactful tenure at the Bank of Japan, where he served for a decade, shaping the nation's monetary...

Continue Reading
APA Corporation Discusses Key Insights for Q3 2025 Results

Updated Category News Views 269

Insights into APA Corporation's Third-Quarter 2025 APA Corporation (NASDAQ: APA) has shared important details about its projected financial and operational outcomes for the third quarter of 2025. This information aims to guide investors and analysts in their own assessments, focusing on factors expected to influence the company's performance. Estimated Average Realized...

Continue Reading
FibroGen's Strategic Move with AstraZeneca Approved Sale

Updated Category News Views 145

FibroGen Secures Approval for Strategic Sale FibroGen, Inc. (NASDAQ: FGEN), based in San Francisco, has officially received approval from the China State Administration for Market Regulation for the sale of FibroGen International (Hong Kong) Ltd. to AstraZeneca Treasury Limited. This key decision marks a significant milestone as the company moves forward with its plans...

Continue Reading
Curaleaf Secures $100 Million Credit Deal to Boost Growth

Updated Category News Views 146

Curaleaf Expands Credit Facilities to Fuel Business Growth Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF), a prominent player in the cannabis sector, has made headlines by upscaling its revolving credit facility to a whopping $100 million with Needham Bank. This move marks a pivotal moment in the cannabis financing landscape. A Landmark Financing Achievement Boris...

Continue Reading